Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

Active, not recruiting

Plain-English translation of NCT05675436 on ClinicalTrials.gov ↗ · Source last updated October 2026 · How we translate trials

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Enrollment target

~6 participants

Started

May 2024

Primary completion

October 2027

Age range

16 Years – 80 Years

Last updated on clinicaltrials.gov in October 2026.